Diphtheria Returns Across Europe as Vaccination Rates Drop
Diphtheria is 200 years old, but the disease continues to affect vulnerable populations across Europe and globally, Irish Medical Times reported.
- Diphtheria is caused by the bacterium Corynebacterium diphtheriae, which releases a tissue-damaging toxin that forms a false membrane in the throat.
- Global vaccination programs initiated by the World Health Organization in 1974 drastically reduced cases, but recent spikes have emerged among incompletely vaccinated groups, migrants, and asylum seekers.
- Ireland recorded 4,942 unvaccinated children in recent data, with national immunisation uptake for third-dose diphtheria vaccines dropping to 90 percent in late 2025.
Deadly Outbreaks Claimed Presidential Children
Historically, diphtheria was one of the deadliest childhood infections, causing devastating outbreaks with a high death toll. Included among the deaths were the children of three US presidents – Abraham Lincoln, James A. Garfield, and Grover Cleveland, according to Irish Medical Times. Thomas Jefferson, who served as the fourth president, additionally lost a child to a putrid sore throat that is widely suspected to have been diphtheria.
Four hundred years ago, in 1613, Spain endured a diphtheria epidemic so devastating that it became known as El Año de los Garotillos, or the Year of the Strangulations. In 1826, French physician Pierre Bretonneau discovered the C. diphtheriae bacterium and named it diphtérite, the Greek word for leather.
Two Parisian doctors, Roux and Alexandre Yersin, isolated the toxin responsible for severe symptoms in 1888. Subsequently, German doctor Emil von Behring collaborated with Japanese bacteriologist Kitasato Shibasaburo to develop antitoxins, earning the first-ever Nobel Prize for Physiology or Medicine in 1901.
Vaccine Cuts Death Rates After 1924
The discovery of a vaccine in 1924 drastically reduced the incidence of diphtheria infection. In 1926, the first alum-precipitated diphtheria toxoid vaccine was licensed in the US, developed by British immunologist Alexander Thomas Glenny. In the UK, diphtheria was the second leading cause of death in children after pneumonia before mass immunisation began in 1942. Cases gradually decreased after the World Health Organization began the universal childhood vaccination programme in 1974.
Despite these interventions, diphtheria rates globally remain a public health concern, with Europe seeing a notable spike in cases in 2022. A report in Eurosurveillance described over 500 cases in Germany between 2017 and 2025, including five deaths. Between February and November 2022, strains of toxigenic C. diphtheriae were isolated from 50 asylum seekers in the UK, mostly men aged between 14 and 25 years.
Clinical Presentation and Diagnosis
Diphtheria is highly infectious and spreads through respiratory droplets when an infected person coughs or sneezes, by touching open sores or ulcers of an infected person, or via contaminated surfaces. Once the bacterium enters the nasopharynx, it releases a toxin that travels in the bloodstream to the heart muscle, peripheral nerves, and kidneys.
Symptoms appear two to five days after infection, including a characteristic greyish-white membrane over the tonsils and throat that causes swollen neck, breathing difficulties, and suffocation. Diagnosis is based on clinical presentation along with bacterial culture to detect C. diphtheriae and an Elek test to detect diphtheria toxin, alongside PCR detection of the tox gene.
Vaccination Rates in Ireland
In 1948, 521 cases of diphtheria were reported in Ireland. Following the introduction of the DTP vaccine in 1952 and 1953, case numbers declined progressively until none were reported in 1968. After a gap of nearly 50 years, one case was reported in 2015 and another in 2016.
Research published in The Lancet revealed that only 91 per cent of Irish children received vaccinations in 2023, leaving nearly 5,000 youngsters completely unprotected by any vaccine doses. Data from the Health Protection Surveillance Centre showed that immunization rates across the country for the third dose of diphtheria vaccines fell to 90 per cent during the third quarter of 2025, whereas coverage for the 4-in-1 booster upon school entry stands at roughly 89.9 per cent.
Irish Medical Times reported that high vaccination rates and greater awareness among clinicians, microbiologists, and public health services are necessary to enable quick diagnosis and treatment, as well as to stop further transmission immediately.
“Diphtheria, the ‘strangling angel’ has not gone away,” wrote Dr Catherine Conlon, a public health doctor in Cork, in Irish Medical Times.
Disclaimer: The information provided in this article is for educational and scientific communication purposes only and does not constitute medical advice. Always consult with a qualified healthcare provider regarding any medical condition, diagnosis, or treatment plan.